Clinical trials in lung cancer focus on innovative therapies like targeted treatments, immunotherapy (e.g., checkpoint inhibitors), and personalized medicine to improve survival rates. Emerging therapies also include CAR-T cell therapy, gene editing, and combination treatments for better patient outcomes.